Department of Surgery, Boston Medical Center, Boston, Massachusetts.
Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Ann Surg. 2021 Jan 1;273(1):3-9. doi: 10.1097/SLA.0000000000004451.
To understand the role of racial residential segregation on Black-White disparities in breast cancer presentation, treatment, and outcomes.
Racial disparities in breast cancer treatment and outcomes are well documented. Black individuals present at advanced stage, are less likely to receive appropriate surgical and adjuvant treatment, and have lower overall and stage-specific survival relative to White individuals.
Using data from the Surveillance, Epidemiology, and End Results program, we performed a retrospective cohort study of Black and White patients diagnosed with invasive breast cancer from 2005 to 2015 within the 100 most populous participating counties. The racial index of dissimilarity was used as a validated measure of residential segregation. Multivariable regression was performed, predicting advanced stage at diagnosis (stage III/IV), surgery for localized disease (stage I/II), and overall stage-specific survival.
After adjusting for age at diagnosis, estrogen/progesterone receptor status, and region, Black patients have a 49% greater risk (relative risk [RR] 1.49 95% confidence interval [CI] 1.27, 1.74) of presenting at advanced stage with increasing segregation, while there was no observed difference in Whites (RR 1.04, 95% CI 0.93, 1.16). Black patients were 3% less likely to undergo surgical resection for localized disease (RR 0.97, 95% CI 0.95, 0.99) with increasing segregation, while Whites saw no significant difference. Black patients had a 29% increased hazard of death (RR 1.29, 95% CI 1.04, 1.60) with increasing segregation; there was no significant difference among White patients.
Our data suggest that residential racial segregation has a significant association with Black-White racial disparities in breast cancer. These findings illustrate the importance of addressing structural racism and residential segregation in efforts to reduce Black-White breast cancer disparities.
了解种族居住隔离对黑人和白人乳腺癌发病、治疗和结局差异的影响。
乳腺癌治疗和结局的种族差异已得到充分证实。与白人相比,黑人患者发病时处于晚期、接受适当手术和辅助治疗的可能性较低、整体和特定分期的生存率也较低。
我们利用监测、流行病学和最终结果(SEER)计划的数据,对 2005 年至 2015 年期间在 100 个人口最多的参与县内诊断为浸润性乳腺癌的黑人和白人患者进行了回顾性队列研究。种族不相似指数(racial index of dissimilarity)被用作居住隔离的有效衡量指标。采用多变量回归预测诊断时的晚期(III/IV 期)、局限性疾病的手术(I/II 期)和整体特定分期的生存率。
在调整了诊断时的年龄、雌激素/孕激素受体状态和区域后,随着隔离程度的增加,黑人患者出现晚期发病的风险增加了 49%(相对风险[RR]1.49,95%置信区间[CI]1.27,1.74),而白人患者则没有观察到差异(RR1.04,95%CI0.93,1.16)。随着隔离程度的增加,黑人患者接受局部疾病手术切除的可能性降低了 3%(RR0.97,95%CI0.95,0.99),而白人患者则没有显著差异。随着隔离程度的增加,黑人患者的死亡风险增加了 29%(RR1.29,95%CI1.04,1.60);而白人患者则没有显著差异。
我们的数据表明,居住种族隔离与乳腺癌中黑人和白人之间的种族差异有显著关联。这些发现表明,在努力减少黑人和白人乳腺癌差异时,解决结构性种族主义和居住隔离问题非常重要。